38.6c New Delhi, India, Tuesday, January 20, 2026
Top Stories Supreme Court
Political NEWS Legislative Corner Celebstreet International Videos
Subscribe Contact Us
close
Crime, Police And Law

Complaint Registered Against Ramdev, Patanjali Over the Alleged Corona Cure Coronil

By Harshil Jain      29 June, 2020 04:52 PM      3 Comments
Complaint Registered Against Ramdev, Patanjali Over the Alleged Corona Cure Coronil

On Tuesday 23 June 2020, a criminal complaint has been filed against Baba Ramdev, Convener of the Patanjali Research Institute, and Acharya Balakrishna, Managing Director of Patanjali Ayurved Ltd., in the court of Chief Judicial Magistrate Mukesh Kumar in Bihar. The complainant alleged that they have misled and put at risk the lives of lakhs of people by claiming to have developed a medicine that treats COVID-19.

The complaint was filed by Tamanna Hashmi, who is a social worker and is often in news for his numerous court complaints against politicians over various issues. The matter has been posted for hearing on 30 June 2020.

He sought registration of a case against the accused under IPC sections 420 (cheating and dishonesty inducing delivery of property), 120B (criminal conspiracy), and 270 (malignant act likely to spread infection of diseases dangerous to life) et cetera.

On Friday 26 June 2020, a similar complaint was filed in Jaipurs Jyoti Nagar Police Station. The complaint included yoga guru Ramdev, Patanjali CEO Aacharya Balkrishna, scientist Anurag Varshney, National Institute of Medical Science Chairman Dr. Balbir Singh Tomar, and Director Dr. Anurag Tomar, as accused.

It was registered under various sections of IPC including s. 420. The complainant, Balram Jakhar, said that TheFIR was filed against five people, including Ramdev for indulging in misleading propagation of Coronil.

Earlier on Tuesday 23 June 2020, the Ministry of AYUSH had issued a statement in which it said that it was not aware of the medicine that was being prepared by the Ayurveda company. Thereafter, it sought details from Patanjali about the alleged corona-cure Coronil including the medicines components, name, and results among others. It also asked Patanjali to refrain from advertising the medicine.

Ministry of AYUSH has taken cognizance of the news being recently flashed in the media about Ayurvedic medicines developed for the treatment of COVID-19 by Patanjali Ayurved Ltd. Facts of the claim and details of the stated scientific study are not known to the Ministry, the ministry had said in a statement.

While AYUSH Ministry has sought details from Patanjali, the Rajasthans Health Department has served a notice to the National Institute of Medical Science hospital in Jaipur, seeking an explanation on conducting trials of Patanjali Ayurveds drug Coronil on coronavirus patients.

Balbir Singh, one of the accused in the complaint, has denied all allegations and claimed that Patanjali had permission to conduct Coronil trials on patients. He said, We had all required permissions for conducting the trial on patients. Prior permission for testing was taken from Clinical Trials Registry- India, which is a body of Indian Council of Medical Research. I have papers to show permission. The question of whether Coronil should have been propagated as an immunity booster or cure should be asked from Patanjali. We had informed the Rajasthan Health Department on June 2, he added.



Share this article:



John Doe
Ms. Athena Cole Dec 24, 2020

Papua New Guinea

John Doe
Francesco Conn Oct 12, 2020

Communications

John Doe
Mrs. Annamae Morar Sep 01, 2020

quantifying

Leave a feedback about this
TRENDING NEWS

accused-need-not-appear-on-every-date-after-bail-in-appeals-sc
Trending Judiciary
Accused Need Not Appear on Every Date After Bail in Appeals: SC [Read Order]

Supreme Court rules accused on bail after suspension of sentence need not appear on every hearing date in appellate or revisional courts.

19 January, 2026 12:47 PM
delhi-hc-upholds-press-councils-rejection-of-editors-guilds-claim-in-15th-press-council-constitution
Trending Judiciary
Delhi HC Upholds Press Council’s Rejection of Editors Guild’s Claim in 15th Press Council Constitution [Read Judgment]

Delhi High Court upheld Press Council of India’s rejection of Editors Guild’s claim, citing delay and non-compliance, and declined to interfere in 15th Press Council constitution.

19 January, 2026 01:39 PM

TOP STORIES

madras-hc-seeks-larger-bench-to-reconsider-bar-on-enrolment-of-law-graduates-with-pending-criminal-cases
Trending Judiciary
Madras HC Seeks Larger Bench To Reconsider Bar On Enrolment Of Law Graduates With Pending Criminal Cases [Read Order]

Madras High Court refers to larger bench to reconsider bar on enrolment of law graduates with pending criminal cases under Advocates Act.

15 January, 2026 05:28 PM
madras-hc-state-organizes-jallikattu-at-avaniyapuram-private-committees-cannot-claim-independent-right
Trending Judiciary
Madras HC: State Organizes Jallikattu at Avaniyapuram; Private Committees Cannot Claim Independent Right [Read Order]

Madras High Court rules that only the State can organize Jallikattu at Avaniyapuram; private committees have no independent right to conduct the event.

15 January, 2026 05:52 PM
sc-delivers-split-verdict-on-section-17a-of-prevention-of-corruption-act-refers-matter-to-larger-bench
Trending Judiciary
SC Delivers Split Verdict on Section 17A of Prevention of Corruption Act, Refers Matter to Larger Bench [Read Judgment]

Supreme Court delivers a split verdict on Section 17A of the Prevention of Corruption Act, with judges differing on its validity and referring the issue to a larger bench.

15 January, 2026 08:04 PM
daughter-in-law-widowed-after-father-in-laws-death-entitled-to-maintenance-from-his-estate-sc
Trending Judiciary
Daughter-in-Law Widowed After Father-in-Law’s Death Entitled to Maintenance from His Estate: SC [Read Judgment]

Supreme Court rules that a daughter-in-law widowed after her father-in-law’s death can claim maintenance from his estate under Hindu law.

15 January, 2026 09:03 PM

ADVERTISEMENT


Join Group

Signup for Our Newsletter

Get Exclusive access to members only content by email